Groin incisions in vascular surgery have complications in up to 30% of cases at 30 days, resulting in reductions in patient quality of life and increased costs. Prior attempts at reducing this complication rate have been largely unsuccessful. The purpose of this study is to determine the feasibility of routine Vialize use for vascular surgeries involving a groin incision and to determine the rates of surgical site infection/dehiscence in such patients receiving subcutaneous Vialize.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
50
Any patients undergoing surgeries involving a groin incision (e.g., femoropopliteal bypass, aortofemoral bypass, loop thigh graft, femoral exposure for delivery of device) will receive Vialize subcutaneously.
UF Health Heart & Vascular Hospital
Gainesville, Florida, United States
The rate of infection at 90-day post-op follow-up in patients receiving Vialize during vascular surgeries involving a groin incision.
Aim 1
Time frame: 90-day post-op follow-up
The patient quality of life (EQ-5D)
Time frame: 90-day post-op follow-up
return to OR for groin infection
Time frame: 90-day post-op follow-up
Readmission or prolongation of the index admission for groin infection
Time frame: 90-day post-op follow-up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.